Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dna X (SONM) Free Cash Flow (2018 - 2025)

Historic Free Cash Flow for Dna X (SONM) over the last 8 years, with Q3 2025 value amounting to -$7.0 million.

  • Dna X's Free Cash Flow fell 116967.51% to -$7.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$26.0 million, marking a year-over-year decrease of 47278.93%. This contributed to the annual value of -$8.7 million for FY2024, which is 11281.8% down from last year.
  • Latest data reveals that Dna X reported Free Cash Flow of -$7.0 million as of Q3 2025, which was down 116967.51% from -$4.9 million recorded in Q2 2025.
  • Dna X's Free Cash Flow's 5-year high stood at $820000.0 during Q2 2023, with a 5-year trough of -$17.6 million in Q4 2021.
  • In the last 5 years, Dna X's Free Cash Flow had a median value of -$4.2 million in 2023 and averaged -$4.5 million.
  • In the last 5 years, Dna X's Free Cash Flow skyrocketed by 11085.93% in 2022 and then tumbled by 475151.52% in 2025.
  • Quarter analysis of 5 years shows Dna X's Free Cash Flow stood at -$17.6 million in 2021, then soared by 87.35% to -$2.2 million in 2022, then soared by 83.69% to -$363000.0 in 2023, then crashed by 1144.35% to -$4.5 million in 2024, then plummeted by 55.72% to -$7.0 million in 2025.
  • Its Free Cash Flow stands at -$7.0 million for Q3 2025, versus -$4.9 million for Q2 2025 and -$9.6 million for Q1 2025.